Pharmhouse Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 2014 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -299,887.0% | – | – | – | -136.0% | – | |
| – | +37.9% | -19.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +57,186.0% | |
| – | – | +2,071.1% | – | – | – | -399,735.9% | – | – | +2,231.4% | -98.0% | -608.1% | |
| – | -75.7% | -72.1% | -100.0% | – | – | – | -99.4% | -100.0% | – | – | +33.3% | |
| – | -75.7% | – | – | – | – | – | -99.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +27.2% | |
| – | -99.7% | -6,120.7% | – | – | – | – | -97.7% | – | – | – | +21.2% | |
| – | – | – | – | – | – | – | -200.0% | – | – | +100.0% | -157.3% | |
| – | – | – | – | – | – | -411,078.4% | – | – | – | -136.0% | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.